- Home
- GECC vs CLNN Comparison
GECC vs CLNN Comparison
Compare GECC & CLNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GECC
- CLNN
- Stock Information
- Founded
- GECC 2016
- CLNN 2012
- Country
- GECC United States
- CLNN United States
- Employees
- GECC N/A
- CLNN N/A
- Industry
- GECC Finance: Consumer Services
- CLNN Biotechnology: Pharmaceutical Preparations
- Sector
- GECC Finance
- CLNN Health Care
- Exchange
- GECC Nasdaq
- CLNN Nasdaq
- Market Cap
- GECC 127.9M
- CLNN 120.6M
- IPO Year
- GECC N/A
- CLNN N/A
- Fundamental
- Price
- GECC $7.38
- CLNN $9.36
- Analyst Decision
- GECC Buy
- CLNN Strong Buy
- Analyst Count
- GECC 2
- CLNN 6
- Target Price
- GECC $10.75
- CLNN $32.67
- AVG Volume (30 Days)
- GECC 108.1K
- CLNN 134.4K
- Earning Date
- GECC 11-04-2025
- CLNN 11-13-2025
- Dividend Yield
- GECC 20.70%
- CLNN N/A
- EPS Growth
- GECC N/A
- CLNN N/A
- EPS
- GECC N/A
- CLNN N/A
- Revenue
- GECC $46,553,000.00
- CLNN $214,000.00
- Revenue This Year
- GECC $30.29
- CLNN N/A
- Revenue Next Year
- GECC N/A
- CLNN $1,363.77
- P/E Ratio
- GECC N/A
- CLNN N/A
- Revenue Growth
- GECC 17.68
- CLNN N/A
- 52 Week Low
- GECC $7.18
- CLNN $2.28
- 52 Week High
- GECC $11.46
- CLNN $13.50
- Technical
- Relative Strength Index (RSI)
- GECC 38.94
- CLNN 52.56
- Support Level
- GECC $7.27
- CLNN $8.29
- Resistance Level
- GECC $7.60
- CLNN $8.86
- Average True Range (ATR)
- GECC 0.31
- CLNN 1.14
- MACD
- GECC 0.02
- CLNN -0.17
- Stochastic Oscillator
- GECC 13.15
- CLNN 51.30
About GECC Great Elm Capital Corp.
Great Elm Capital Corp is an externally managed, non-diversified closed-end management investment company. It generate both income and capital appreciation through debt and income-generating equity investments, including investments in finance businesses.
About CLNN Clene Inc.
Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements). Products includes CNM-Au8, CNM-ZnA, CNM-AgZn17, rMetx, KHC46.